Valuation (5%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -43.54 | N/A |
| PEG Ratio (TTM) | -2.51 | N/A |
| P/S Ratio (TTM) | 19.72 | N/A |
| P/B Ratio (TTM) | 7.64 | N/A |
| P/FCF Ratio (TTM) | -2,263.20 | N/A |
| Price to 5YR AVG Earnings Ratio | -55.38 | N/A |
| Price to 5YR AVG FCF Ratio | -70.15 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.82% | N/A |
| ROE (TTM) | -17.33% | N/A |
| Net Profit Margin (TTM) | -45.29% | N/A |
| ROIC 5YR AVG | -25.53% | N/A |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -78.68% | -142.59% | -381.16% |
| Revenue | 6.86% | 0.94% | 4.82% |
| Net Income | -80.37% | -146.42% | -346.43% |
| Cash Flow | 201.93% | -7,583.12% | -4,893.03% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.24 | N/A |
| Quick Ratio (TTM) | 5.84 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | -2,593.85 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 23.40 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 10.59% | N/A |